Bliss GVS Pharma Limited: Business Overview, Financials & Competitive Analysis
Bliss GVS Pharma Limited scores 5/10 on the AskCyborg Cyborg Score (Mixed). Specialty pharma player with defensible niche in suppositories/pessaries seeking to revitalize growth through geographic expansion and operational improvements. Bliss GVS has strong market positioning as a global leader in specialty formulations with solid financial health (near zero debt). However, weak sales growth and moderate scale limit upside. Recent.
What is Bliss GVS Pharma Limited's industry? Bliss GVS Pharma Limited (blissgvs.com) operates in Pharmaceutical Manufacturing - Specialty & Generic. AskCyborg classifies Bliss GVS Pharma Limited under Pharmaceutical Manufacturing - Specialty & Generic in its company registry.
Bliss GVS Pharma Limited, incorporated in 1984, is engaged in manufacturing, marketing, trading and export of pharmaceutical formulations in the form of suppositories, pessaries, capsules, tablets, and syrups. The com...
Cyborg Score thesis
Specialty pharma player with defensible niche in suppositories/pessaries seeking to revitalize growth through geographic...
Read the full analyst-debate transcript →Get the Latest Bliss GVS Pharma Limited Report
Up-to-date AI-powered research, analyst debate audio & saved-company playlists
Get Current Report FreeBliss GVS Pharma Limited Overview
Pro stress-test →Bliss GVS Pharma Limited, incorporated in 1984, is engaged in manufacturing, marketing, trading and export of pharmaceutical formulations in the form of suppositories, pessaries, capsules, tablets, and syrups. The company is the world's largest manufacturer of suppositories and pessaries with a diversified portfolio serving domestic and international markets.
Strategic Profile
Pro stress-test →The company manufactures, markets, and exports over 150 branded formulations across 60+ therapeutic segments, including anti-malarial, anti-fungal, anti-bacterial, antibiotic, anti-inflammatory, contraceptive, and anti-diabetic. The company is almost debt free, providing financial flexibility, though the company has delivered a poor sales growth of 3.27% over past five years.
Competitive Landscape
Pro stress-test →Bliss GVS operates in the specialty pharmaceutical segment, competing with major Indian pharma companies like Sun Pharma, Cipla, and Lupin, and international players in generic formulations. Its competitive advantage lies in specialized manufacturing capabilities for suppositories and pessaries, areas where it holds global leadership. However, it faces pressure from larger generics manufacturers with broader portfolios and stronger R&D capabilities.
Industry Context
Bliss GVS Pharma Limited operates in Pharmaceutical Manufacturing - Specialty & Generic.
Key facts
Founded: 1984 · Headquarters: Mumbai, India · Revenue: ₹810 Cr (FY2024, ~$97M USD) · Market cap: ₹2,231 Cr (~$268M USD)